Core Viewpoint - Hunan Dajia Weikang Pharmaceutical Co., Ltd. is preparing for an IPO in Hong Kong, aiming to raise funds for expanding its retail network, upgrading logistics, enhancing marketing, and supplementing working capital [1] Group 1: Company Overview - Dajia Weikang is a comprehensive pharmaceutical service provider focused on offering a full range of health services, including the distribution and retail of pharmaceuticals and medical devices [1] - The company operates a distribution network and chain pharmacies across Hunan Province and other regions, providing products and professional services such as medication consultation and health management [1] - Dajia Weikang has established long-term partnerships with well-known domestic and international pharmaceutical manufacturers, ensuring timely and safe drug supply through integrated supply chain resources and digital management systems [1] Group 2: IPO Details - The IPO is sponsored by CITIC Construction Investment International and Huatai Financial Holdings (Hong Kong) [1] - The funds raised from the IPO will be allocated to the following purposes: expanding and optimizing the pharmaceutical retail network, upgrading logistics centers and supply chain management systems, enhancing marketing and brand building, and supplementing working capital for general corporate purposes [1]
达嘉维康：综合医药服务商通过港交所聆讯，或很快香港上市